Evidence map›Paper›PMID 39462058›Full record

ArticleScientific reports2024

Grating-based phase-contrast computed tomography for breast tissue at an inverse compton source.

Daniel Berthe, Lisa Heck, Sandra Resch, Martin Dierolf, Johannes Brantl, Benedikt Günther, Christian Petrich, Klaus Achterhold, Franz Pfeiffer, Susanne Grandl and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel BertheChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany. Daniel.Berthe@tum.de.
Lisa HeckChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Sandra ReschChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Martin DierolfChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Johannes BrantlChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Benedikt GüntherChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Christian PetrichChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Klaus AchterholdChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Franz PfeifferChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Susanne GrandlDepartment of Diagnostic and Interventional Radiology, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, München, 81675, Germany.
Karin HellerhoffDepartment of Diagnostic and Interventional Radiology, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, München, 81675, Germany.
Julia HerzenChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The introduction of mammography screening programs has significantly reduced breast cancer mortality rates. Nevertheless, some lesions remain undetected, especially in dense breast tissue. Studies have shown that phase-contrast imaging can improve breast cancer diagnosis by increasing soft tissue contrast. Furthermore, grating-based phase-contrast imaging enables the simultaneous acquisition of absorption, phase-contrast, and scattering, so-called dark-field images. The latter allows the classification of microcalcifications. In addition, breast computed tomography (BCT) systems can identify and discriminate overlapping but clinically relevant structures. This study investigates the benefit of combining grating-based phase-contrast with BCT. We explore the potential of grating-based phase-contrast breast computed tomography (gbpc-BCT) with a breast phantom and a freshly dissected fibroadenoma. Improved image contrast could be achieved with radiation doses comparable to those used in clinical BCT.

Indexed as

Breast NeoplasmsMammographyPhantoms, ImagingTomography, X-Ray ComputedBreastFemaleFibroadenomaHumans

Identifiers

PMID39462058
PMCPMC11513984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.